Home › Multiple Myeloma › New Jersey › Edison
Pag-aaral pangklinika para sa Multiple Myeloma sa Edison, NJ
Isang pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Edison. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Nagre-recruitPhase 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Nagre-recruitPhase 3
- Astera Cancer Care, East Brunswick · 6 mi ang layo
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Nagre-recruitPhase 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Nagre-recruitPhase 3
- MSK Basking Ridge, Basking Ridge · 15 mi ang layo
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Nagre-recruitPhase 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Nagre-recruitObservasyonal na pag-aaral
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Nagre-recruitPhase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi ang layo
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Nagre-recruit
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi ang layo
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Nagre-recruitPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 3
- Astera Cancer Care, East Brunswick · 6 mi ang layo
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Nagre-recruitPhase 3
- MSK Basking Ridge, Basking Ridge · 15 mi ang layo
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Nagre-recruitPhase 3
- Research Site, East Brunswick · 6 mi ang layo
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Nagre-recruitPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Nagre-recruitPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Nagre-recruitMaagang Phase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3 mi ang layo
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3 mi ang layo
A Dietary Study for People With Multiple Myeloma
Nagre-recruit
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Nagre-recruitPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Nagre-recruitPhase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi ang layo
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
Pag-aaral para sa Multiple Myeloma sa ibang lungsod
- New York City, NY59 pag-aaral
- Boston, MA45 pag-aaral
- Atlanta, GA42 pag-aaral
- Houston, TX39 pag-aaral
- Durham, NC36 pag-aaral
- Nashville, TN31 pag-aaral
- Denver, CO26 pag-aaral
- St. Louis, MO26 pag-aaral
- Rochester, MN25 pag-aaral
- Columbus, OH25 pag-aaral
- Chicago, IL24 pag-aaral
- Milwaukee, WI23 pag-aaral
Iba pang pag-aaral sa Edison
- Kanser sa Suso70 pag-aaral
- Non-Small Cell Lung Cancer50 pag-aaral
- Kanser (lahat ng uri)33 pag-aaral
- Kanser sa Prostate29 pag-aaral
- Colorectal Cancer25 pag-aaral
- Kanser sa Baga25 pag-aaral
- Kanser sa Pantog23 pag-aaral
- Metastatic Cancer20 pag-aaral
- Kanser ng Endometrium20 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
- Kanser sa Ovary19 pag-aaral
- Kanser sa Pancreas18 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.